Virios Therapeutics VIRI Combination Antiviral Approach Investor Presentation

Virios Therapeutics presents a novel, synergistic combination antiviral approach designed to deliver clinical benefits for patients with suspected viral-mediated illness. The presentation showcases the company's experienced management team and board with extensive drug development and commercialization expertise, including leadership from key figures in antiviral drug development and prior successful pharmaceutical transactions.